Development of novel benzo[ d ][1,2,3]triazole-acetohydrazone derivatives as potential therapeutic agents: synthesis, SAR study, inhibition of carbohydrate metabolism enzymes, and aldose reductase supported by molecular modelling simulation

). Consequently, compound 11 holds promise as a lead molecule for developing novel therapeutic agents targeting α-amylase, α-glucosidase, and aldose reductase for diabetes management. Furthermore, molecular docking and molecular dynamics simulations (100 ns) elucidated stable interactions between compound 11 and the catalytic pockets of both α-amylase and α-glucosidase, primarily mediated by hydrogen bonding and hydrophobic interactions. The ADME analysis revealed an acceptable physicochemical profile, characterized by good aqueous solubility and a minimal predicted risk of CYP-mediated drug-drug interaction. Finally, these findings indicate that benzotriazole derivative 11 may serve as a promising scaffold for further optimization toward a multi-target anti-diabetic drug development agent.

Authors

Institutions

Publication Details

Journal
RSC Advances
Published
2026-11-17
DOI
https://doi.org/10.1039/d6ra06631c
Primary Topic
Natural Antidiabetic Agents Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Development of novel benzo[ d ][1,2,3]triazole-acetohydrazone derivatives as potential therapeutic agents: synthesis, SAR study, inhibition of carbohydrate metabolism enzymes, and aldose reductase supported by molecular modelling simulation

Mohga Basseem, Ahmed Ragab, Wael M. Aboulthana, Mohamed H. El-Naggar et al.
3 links
RSC Advances
Natural Antidiabetic Agents Studies
article

Development of novel benzo[ d ][1,2,3]triazole-acetohydrazone derivatives as potential therapeutic agents: synthesis, SAR study, inhibition of carbohydrate metabolism enzymes, and aldose reductase supported by molecular modelling simulation

Mohga Basseem, Ahmed Ragab, Wael M. Aboulthana, Mohamed H. El-Naggar, Ahmed T. Elhendawy, Mohamed E. Belasy
article en

Abstract

). Consequently, compound 11 holds promise as a lead molecule for developing novel therapeutic agents targeting α-amylase, α-glucosidase, and aldose reductase for diabetes management. Furthermore, molecular docking and molecular dynamics simulations (100 ns) elucidated stable interactions between compound 11 and the catalytic pockets of both α-amylase and α-glucosidase, primarily mediated by hydrogen bonding and hydrophobic interactions. The ADME analysis revealed an acceptable physicochemical profile, characterized by good aqueous solubility and a minimal predicted risk of CYP-mediated drug-drug interaction. Finally, these findings indicate that benzotriazole derivative 11 may serve as a promising scaffold for further optimization toward a multi-target anti-diabetic drug development agent.

RSC Advances
Al-Azhar University (EG), University of Sharjah (AE), National Research Centre (EG), Galala University (EG), ElSewedy University of Technology (EG)
Good health and well-being
Natural Antidiabetic Agents Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon